Monitoring Gesetzessammlung

Gesetze und Verordnungen USA alphabetisch

A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z
0 1 2 3 4 5 6 7 8 9
§ 360a–2 - Susceptibility test interpretive criteria for microorganisms
21 USC 360a–2
§ 360aa - Recommendations for investigations of drugs for rare diseases or conditions
21 USC 360aa
§ 360aaa to 360aaa–6 - Omitted
21 USC 360aaa to 360aaa–6
§ 360b - New animal drugs
21 USC 360b
§ 360b–1 - Priority zoonotic animal drugs
21 USC 360b–1
§ 360bb - Designation of drugs for rare diseases or conditions
21 USC 360bb
§ 360bbb - Expanded access to unapproved therapies and diagnostics
21 USC 360bbb
§ 360bbb–0 - Expanded access policy required for investigational drugs
21 USC 360bbb–0
§ 360bbb–0a - Investigational drugs for use by eligible patients
21 USC 360bbb–0a
§ 360bbb–1 - Dispute resolution
21 USC 360bbb–1
§ 360bbb–2 - Classification of products
21 USC 360bbb–2
§ 360bbb–3 - Authorization for medical products for use in emergencies
21 USC 360bbb–3
§ 360bbb–3a - Emergency use of medical products
21 USC 360bbb–3a
§ 360bbb–3b - Products held for emergency use
21 USC 360bbb–3b
§ 360bbb–3c - Expedited development and review of medical products for emergency uses
21 USC 360bbb–3c
§ 360bbb–4 - Countermeasure development, review, and technical assistance
21 USC 360bbb–4
§ 360bbb–4a - Priority review to encourage treatments for agents that present national security threats
21 USC 360bbb–4a
§ 360bbb–4b - Medical countermeasure master files
21 USC 360bbb–4b
§ 360bbb–5 - Critical Path Public-Private Partnerships
21 USC 360bbb–5
§ 360bbb–5a - Emerging technology program
21 USC 360bbb–5a
Verwendung von Cookies.

Durch die Nutzung dieser Website akzeptieren Sie automatisch, dass wir Cookies verwenden. Cookie-Richtlinie

Akzeptieren
Markierungen
Leseansicht